Fourth Quarter and Full Year 2023 Earnings Call Jim Zallie President and CEO James Gray Executive Vice President and CFO Non-GAAP Financial Measures This presentation provides information aboutadjusted dilutedearnings per share (“adjustedEPS”),adjusted operatingincome, adjustedeffective income tax rate, andother financial measures (collectively,the “non-GAAP financial measures”) which are not measurements of financial performance calculated in accordance with U.S. generally accepted accounting principles (“ ...

财务数据和关键指标变化 - 第三季度净销售额约20亿美元,同比增长1% [21] - 毛利润同比增长13%,毛利率达到20.7% [25] - 报告和调整后的营业利润分别为2.13亿美元和2.19亿美元,同比增长15% [10][21] - 报告和调整后的每股收益分别为2.36美元和2.33美元,同比增长48%和35% [21] 各条业务线数据和关键指标变化 - 特殊配料业务年初至今销售额增长6%,毛利率持续扩大 [11] - 纹理解决方案、制药和个人护理以及食品系统业务实现两位数增长 [11] - 核心配料业务在墨西哥市场表现强劲,第三季度营业利润创历史新高 [18] - 美国葡萄糖需求旺盛,生产设施满负荷运转 [19] - 工业配料业务在美国需求稳步回升 [19] 各个市场数据和关键指标变化 - 北美地区净销售额增长3%,营业利润增长36% [26] - 南美地区净销售额下降8%,营业利润下降33%,主要受到能源成本上升影响 [27] - 亚太地区净销售额下降2%,营业利润增长22% [28] - 欧洲、中东和非洲地区净销售额增长1%,营业利润增长7% [29] 公司战略和发展方向及行业竞争 - 公司将在2024年第一季度重组业务,以更好地服务于纹理和健康解决方案的全球客户 [47] - 重组后将提供更多关于公司产品能力和市场机会的洞见,更好地反映公司的战略价值驱动因素 [47] - 公司正在与客户合作开展再生农业项目,为农民、公司和客户创造增值 [13] - 公司在安全生产、员工关系和企业文化等方面持续表现出色 [15][16] 管理层对经营环境和未来前景的评论 - 公司有信心在2023年创下历史新高业绩,体现了多元化产品组合和客户关系的力量 [46] - 公司看到第三季度以来的销量改善趋势将持续,对2024年前景持谨慎乐观态度 [45][59] - 公司已与大型客户续签多年合同,将支持2024年的利润增长 [56][57] - 公司有信心利用定价中心等能力应对不同的市场环境,包括原材料价格下降的情况 [58][123][124] 问答环节重要的提问和回答 问题1 **Kristen Owen 提问** 询问重组对内部协同效应和创新周期的影响 [50][51][52][53] **James Zallie 回答** 重组将更好地服务于纹理和健康解决方案的全球客户,带来运营、销售和市场机会协同 [51][52][53] 问题2 **Ben Theurer 提问** 询问各地区和产品线的销量动态及驱动因素 [62][63][64][65][66][67][69] **James Zallie 和 Jim Gray 回答** - 核心甜味剂和工业淀粉需求相对稳定,食品配料受到去库存影响较大 [64][65][66][67] - 墨西哥市场需求强劲,美国工业淀粉需求回升 [69] - 巴西第三季度需求有所恢复,接近2022年水平 [64] 问题3 **Ben Bienvenu 提问** 询问公司未来资本配置策略,特别是股票回购的空间 [72][73][74] **Jim Gray 回答** - 公司将继续灵活和战略性地部署经营活动产生的超额现金,包括股票回购 [73] - 未来仍有一些增长性投资需求,但公司有足够的闲置产能可以满足 [74]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 Ingredion Incorporated (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of i ...

业绩总结 - 第三季度净销售额为20.33亿美元，同比增长1%[15] - 第三季度毛利为4.21亿美元，毛利率为20.7%，较去年同期增长220个基点[15] - 第三季度调整后每股收益为2.33美元，较去年同期增长0.60美元[15] - 全球特殊产品净销售额同比增长6%[10] - 特殊产品毛利持续扩张，第三季度特殊产品净销售额表现良好[10] 地区业绩 - 北美地区第三季度净销售额同比增长3%，运营利润同比增长36%[19] - 南美地区第三季度净销售额同比下降8%，运营利润同比下降33%[19] - 亚太地区第三季度净销售额同比下降2%，运营利润同比增长22%[20] - 欧洲、中东和非洲地区第三季度净销售额同比增长1%，运营利润同比增长7%[20] 未来展望 - 2023年全年净销售预计将增长中单位数位[25] - 2023年全年调整后营业收入预计将增长高两位数[25] - 2023年全年调整后每股收益预计为9.05至9.45美元[25] - 2023年全年现金运营预计为6.5亿至7.5亿美元[25] - 2023年全年资本支出约为3.1亿美元[25] 预测地区销售 - 预计北美地区净销售将增长5%至10%[27] - 预计南美地区净销售将持平至下降5%[28] - 预计亚太地区净销售将增长5%至10%[28] - 预计EMEA地区净销售将增长40%至45%[28]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 Ingredion Incorporated (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorp ...

Ingredion. Be what's next. Second Quarter 2023 Earnings Call Jim Zallie President and CEO James Gray Executive Vice President and CFO Non-GAAP Financial Measures This presentation provides information about adjusted diluted earnings per share ("adjusted EPS"), adjusted operating income, adjusted effective income tax rate, and other financial measures (collectively, the "non-GAAP financial measures") which are not measurements of financial performance calculated in accordance with U.S. generally accepted acc ...

Ingredion Incorporated (NYSE:INGR) Q2 2023 Earnings Conference Call August 8, 2023 9:00 AM ET Company Participants Noah Weiss - Vice President, Investor Relations Jim Zallie - President and Chief Executive Officer Jim Gray - Executive Vice President and Chief Financial Officer Conference Call Participants Ben Bienvenu - Stephens Inc Andrew Strelzik - BMO Capital Markets Cody Ross - UBS Ben Theurer - Barclays Operator Good day and thank you for standing by. Welcome to the Ingredion Second Quarter 2023 Earnin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 Ingredion Incorporated (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incor ...

Ingredion Incorporated (NYSE:INGR) Q1 2023 Results Conference Call May 3, 2023 9:00 AM ET Company Participants Noah Weiss - VP, IR Jim Zallie - President, CEO & Director Jim Gray - EVP & CFO Conference Call Participants Cody Ross - UBS Ben Theurer - Barclays Adam Samuelson - Goldman Sachs Ben Bienvenu - Stevens Andrew Strelzik - BMO Capital Markets Operator Good day and thank you for standing by. Welcome to the Ingredion First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only m ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION INCORPORATED (Exact name of registrant as specified in its charter) Delaware 22-3514823 (State or other jurisdiction of ...